Navigation Links
Take Fatigue Seriously - Says Researcher

Instead of dismissing grumblings about being tired or exhausted, people should take these complaints seriously// before they lead to a worsened health state or even death, says a University of Alberta researcher investigating fatigue.

Dr. Karin Olson, a U of A professor from the Faculty of Nursing, argues that there are differences between tiredness, fatigue and exhaustion and that recognizing those distinctions will help health-care workers create better treatment plans for their patients. Her findings are published in the current issue of Oncology Nursing Forum.

Olson has studied fatigue in six ill and non-ill populations: shift workers, recreational long distance runners, individuals with cancer in active treatment or palliative settings, and individuals diagnosed with depression or chronic fatigue syndrome. Having worked with cancer patients for many years, she saw how serious fatigue was and the impact it had on the patients’ quality of life. Some patients even withdrew for a potentially curative treatment saying they were “too tired.”

“The kind of fatigue experienced by individuals with cancer is different from the feeling that you or I have at the end of a busy week,” said Olson. “Interestingly, when you start looking at other populations, such as people with chronic illnesses or shift workers and take a broad view, the descriptions of fatigue are the same. Thus, while the reasons for fatigue may vary, the kinds of adaptations required may not.”

Olson, who is currently an Alberta Heritage Foundation for Medical Research (AHFMR) Health Scholar, has created new definitions for tiredness, fatigue and exhaustion and argues that they represent various points on an energy continuum. The amount of energy a person has influences how easily he can adapt to stress that comes his way. Individuals who are tired still have a fair bit of energy, so although they may feel forgetful, and impatient, and experience gradual heaviness or w
'"/>




Page: 1 2 3

Related medicine news :

1. Reduced Fatigue Boosts Mental Health
2. Overcoming Chronic Fatigue
3. Chronic Fatigue, Pain Linked to Sinusitis
4. Helping Cancer Patients Fight Fatigue
5. A Sedentary Childhood Could Lead To Chronic Fatigue Latter In Life
6. Obesity And Chronic Fatigue Related To Snoring
7. Fatigue, Prevalent Among Patients Treated For Breast Cancer
8. Persistent Fatigue Could Be An Early Indicator Of Postpartum Depression
9. Brain Injury, A Consequence Of Glandular Fever Could Trigger Fatigue Syndrome
10. Efficacy Of Sports-Formulated Jelly Beans In Warding Off Fatigue To Be Studied
11. Genetics Might BE The Basis For Chronic Fatigue Syndrome
Post Your Comments:
(Date:12/1/2008)...ARLOTTE, N.C., Dec. 1 I..., Emeka Okafor, will be launching a mobile textin...can Lives Initiative (OMALI), a program of the Saf... the Initiative is to save one million lives in Af... blood testing kits and clinical training. , ...
(Date:12/1/2008)...NTA MONICA, Calif., Dec. 1 TOMS Sh...ched a holiday campaign online at TOMSshoes.com,...s holiday season. For 30,days, from November 20th...oppers to help give 30,000 pairs of shoes to child...ease that is 100% preventable by wearing shoes. By...
(Date:12/1/2008)..., , , , Ideas from U-M physician inc..., Mich., Dec. 1 A bottl...e are all quick and easy gifts to buy and wrap for...ot give something more healthy and beneficial to a... , Staying healthy around the holidays can be ...
(Date:12/1/2008)... JOLLA, Calif., Dec. 1 TorreyPines...nced that oral administration of NGX426, an,AMPA/...trated a statistically,significant reduction in s...d,pain state) and allodynia (pain resulting from ...d to placebo following intradermal injections of c...
Breaking Medicine News(10 mins):Health News:In Recognition of WORLD AIDS DAY, Charlotte Bobcats' Power Forward, Emeka Okafor, Launches Mobile Texting Campaign in Support of the One Million African Lives Initiative 2Health News:TOMS Shoes Embarks on a Holiday Mission: Give 30,000 Pairs in 30 Days! 2Health News:Giving the Gift of Health This Holiday Season 2Health News:Giving the Gift of Health This Holiday Season 3Health News:Giving the Gift of Health This Holiday Season 4Health News:TorreyPines' NGX426, an Oral AMPA/Kainate Receptor Antagonist, Meets Primary Endpoints in Reducing Capsaicin-Induced Pain in Healthy Subjects 2Health News:TorreyPines' NGX426, an Oral AMPA/Kainate Receptor Antagonist, Meets Primary Endpoints in Reducing Capsaicin-Induced Pain in Healthy Subjects 3Health News:TorreyPines' NGX426, an Oral AMPA/Kainate Receptor Antagonist, Meets Primary Endpoints in Reducing Capsaicin-Induced Pain in Healthy Subjects 4Health News:TorreyPines' NGX426, an Oral AMPA/Kainate Receptor Antagonist, Meets Primary Endpoints in Reducing Capsaicin-Induced Pain in Healthy Subjects 5
...als a new immune defense mechanism in normal airwa...ibrosis (CF) are particularly susceptible to bacte...the way to new approaches for treating the disease...enerate and use reactive oxygen species (ROS) to d...
...teroid, can prevent skin abnormalities induced by ...m the December //issue of the American Journal of ... Physiology. The new study also shows how psycholo...d initiate or worsen skin disorders such as psoria...
...g women who grow up in cities or move there from r...// Princess Diana was known to suffer from this e... in the country, and moved to London as a teenager...der in which young women get trapped in a routine ...
...e Family Restaurant at Lloydminister, has tested p...by a virus and affects the liver and causes fever,...iscomfort followed by yellow jaundice a few days l...ion of this virus from the worker to patrons of th...
Other Medicine News:Health News:Newly Discovered Immune Defense May Be Impaired In CF Airways 2Health News:Blocking Glucocorticoid Prevents Stress-Induced Skin Abnormalities 2Health News:Blocking Glucocorticoid Prevents Stress-Induced Skin Abnormalities 3
(Date:11/28/2008)...ll/ -- Eli Lilly and Company,(NYSE: LLY ) has w...DA) from,the U.S. Food and Drug Administration (F...gement of chronic pain. Lilly plans to resubmit th...ata from a recently completed positive study,in c...he decision does not affect duloxetine,s FDA-appro...
(Date:11/25/2008)... , Audio and Web Video Resources to accompan... Blog. Please see the bottom of this release for d... A Mayo Clinic study sho...re having a stroke -- and as a result -- delay see...findings appear in the current issue of Emergency ...
(Date:11/25/2008)...rstCall/ -- Pharmacyclics, Inc.,(Nasdaq: PCYC )...Phase 1,clinical trial with PCI-27483, the compan...IIa inhibitor. The trial was conducted in sixteen ...d pharmacologic effect of,PCI-27483. A single adm...,response in the International Normalized Ratio (...
(Date:11/24/2008)...stCall/ -- Leaders of Schering-Plough Corporation ...ors on the company,s research pipeline, highlighti...6 new entities in clinical trials or under regulat... "Research and development is adding strength an...ansformation," said Fred Hassan, chairman and CEO....
Breaking Medicine Technology:Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5Silent streams 3F Escalating endangerment for North American freshwater fish 4797 1Silent streams 3F Escalating endangerment for North American freshwater fish 4797 2Silent streams 3F Escalating endangerment for North American freshwater fish 4797 3Med School Diversity May Help Whites Care Better for Minorities 26203 1Med School Diversity May Help Whites Care Better for Minorities 26203 2Med School Diversity May Help Whites Care Better for Minorities 26203 3Young African American Males Face Mental Health Crisis 3B Experts Call For New Treatment Strategies and Better Access to Care 26199 1Young African American Males Face Mental Health Crisis 3B Experts Call For New Treatment Strategies and Better Access to Care 26199 2Young African American Males Face Mental Health Crisis 3B Experts Call For New Treatment Strategies and Better Access to Care 26199 3Medco CEO Unveils Pragmatic Blueprint for Health Care Reform 3B Reducing Costs by Upwards of 241 Trillion 26195 1Medco CEO Unveils Pragmatic Blueprint for Health Care Reform 3B Reducing Costs by Upwards of 241 Trillion 26195 2Medco CEO Unveils Pragmatic Blueprint for Health Care Reform 3B Reducing Costs by Upwards of 241 Trillion 26195 3Medco CEO Unveils Pragmatic Blueprint for Health Care Reform 3B Reducing Costs by Upwards of 241 Trillion 26195 4
...ata being presented today at Digestive Disease Wee...- Microbia today,announced the presentation of dat...rated colonic transit and improved bowel function,...le bowel syndrome,(IBS-C). These data also showed ...e of adverse events. Linaclotide is a first-in-cla...
...HEIM, Calif.--(BUSINESS WIRE)--May 21, 2007 - Anti...nal follow-up data on the,company,s Phase 3 invest...(vitespen). The end-of-study results, which reflec... that in a substantial,subset of patients (n = 362...ophage demonstrated a clinically significant,impro...
Other Medicine Technology:Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 2Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 3Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 4Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 5Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 6
Tube for Left Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. X-ray opaque line. Graduated. Single use. St
...Medication Delivery., ,Designed for adolescent an... an additional lumen and injection port for rapid ...hree endotracheal tubes designs which allow for CO...livery without additional adaptors., ETCO2™ ...
...otracheal Instillation of Topical Anesthetic, ,De...cuffed tube incorporates an additional lumen and i...sthetic above and below the cuff., ,SHERIDAN offe...r CO2 monitoring, pressure monitoring or medicatio...
...oring Lumen., ,Designed for neonatal and pediatri...tube incorporates a monitoring lumen within the wa...er lock connector bonded to lumen line provides co...onitoring or syringe irrigation of medication., ,...
Medicine Products: